Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: Successful disease control with cyclosporin

Both anti‐laminin γ1 pemphigoid and bullous pemphigoid are autoimmune subepidermal blistering diseases. The former is rare and characterized by autoantibodies to laminin γ1, a 200‐kDa dermal protein, while the latter is common among the elderly and characterized by autoantibodies to BP180 and BP230,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatology 2015-04, Vol.42 (4), p.394-397
Hauptverfasser: Imanishi, Akiko, Tateishi, Chiharu, Imanishi, Hisayoshi, Sowa-Osako, Junko, Koga, Hiroshi, Tsuruta, Daisuke, Hashimoto, Takashi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 397
container_issue 4
container_start_page 394
container_title Journal of dermatology
container_volume 42
creator Imanishi, Akiko
Tateishi, Chiharu
Imanishi, Hisayoshi
Sowa-Osako, Junko
Koga, Hiroshi
Tsuruta, Daisuke
Hashimoto, Takashi
description Both anti‐laminin γ1 pemphigoid and bullous pemphigoid are autoimmune subepidermal blistering diseases. The former is rare and characterized by autoantibodies to laminin γ1, a 200‐kDa dermal protein, while the latter is common among the elderly and characterized by autoantibodies to BP180 and BP230, both of which are hemidesmosomal proteins. We experienced a 69‐year‐old Japanese male patient with blister formation secondary to erythrodermic psoriasis, which was successfully treated with cyclosporin. The histopathology of erythema corresponded with psoriasis and that of a blistering lesion showed infiltration of neutrophils and eosinophils in and around the subepidermal blisters. Patient immunoglobulin G antibodies labeled both the epidermal and dermal sides of 1 mol/L NaCl‐split human skin by indirect immunofluorescent microscopy and recognized laminin γ1, BP180 and BP230 by immunoblotting. To the best of our knowledge, this is the first report of coexistence of psoriasis and atypical pemphigoid with these three autoantibodies.
doi_str_mv 10.1111/1346-8138.12798
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1671216808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1671216808</sourcerecordid><originalsourceid>FETCH-LOGICAL-i2348-a251e06a68d1f17a6ce9fcd4324377578c9c9643cb7a491f8ec4bd83ffb411193</originalsourceid><addsrcrecordid>eNo9kc1O3DAQx62qqCy0596Qjz0Q8Fdsh1vZ8lGE2q1o1aPlOA4YnDjNJMA-Qx-n79Fnapbdri8ezfx-c5g_Qu8pOaLTO6ZcyExTro8oU4V-hWbbzms0I1znGRNE7aI9gHtCWJFT8gbtslwRnTMyQ78Xvunuwm0KFX4Kwx227RDKVAUPeEg42ia0ocV__9BDfLqgmkxANVWMk0NsAZILdvAbt4PUBwsB8OMYb20f4ATfjM55gHqMuArgLXjsUjv0Ka4dt3QxQTeJ7Vu0U9sI_t3m30c_zs--zy-z668Xn-cfr7PAuNCZZTn1RFqpK1pTZaXzRe0qwZngSuVKu8IVUnBXKisKWmvvRFlpXtelmG5W8H30Yb2369Ov0cNgmgDOx2hbn0YwVCrKqNRET-jBBh3Lxlem60Nj-6X5f8AJyNfAU4h-uZ1TYlb5mFUaZpWGecnHXH06eykmL1t7AQb_vPVs_2Ck4io3P79cmPPFNynV_Mrc8H_C1JIj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1671216808</pqid></control><display><type>article</type><title>Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: Successful disease control with cyclosporin</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Imanishi, Akiko ; Tateishi, Chiharu ; Imanishi, Hisayoshi ; Sowa-Osako, Junko ; Koga, Hiroshi ; Tsuruta, Daisuke ; Hashimoto, Takashi</creator><creatorcontrib>Imanishi, Akiko ; Tateishi, Chiharu ; Imanishi, Hisayoshi ; Sowa-Osako, Junko ; Koga, Hiroshi ; Tsuruta, Daisuke ; Hashimoto, Takashi</creatorcontrib><description>Both anti‐laminin γ1 pemphigoid and bullous pemphigoid are autoimmune subepidermal blistering diseases. The former is rare and characterized by autoantibodies to laminin γ1, a 200‐kDa dermal protein, while the latter is common among the elderly and characterized by autoantibodies to BP180 and BP230, both of which are hemidesmosomal proteins. We experienced a 69‐year‐old Japanese male patient with blister formation secondary to erythrodermic psoriasis, which was successfully treated with cyclosporin. The histopathology of erythema corresponded with psoriasis and that of a blistering lesion showed infiltration of neutrophils and eosinophils in and around the subepidermal blisters. Patient immunoglobulin G antibodies labeled both the epidermal and dermal sides of 1 mol/L NaCl‐split human skin by indirect immunofluorescent microscopy and recognized laminin γ1, BP180 and BP230 by immunoblotting. To the best of our knowledge, this is the first report of coexistence of psoriasis and atypical pemphigoid with these three autoantibodies.</description><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.12798</identifier><identifier>PMID: 25708520</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Aged ; Autoantibodies - metabolism ; Autoantigens - immunology ; BP180 ; Collagen Type XVII ; cyclosporin ; Cyclosporine - therapeutic use ; Dystonin - immunology ; Humans ; Immunosuppressive Agents - therapeutic use ; Laminin - immunology ; laminin γ1 ; Male ; Non-Fibrillar Collagens - immunology ; pemphigoid ; Pemphigoid, Bullous - drug therapy ; Pemphigoid, Bullous - immunology ; Pemphigoid, Bullous - pathology ; psoriasis ; Psoriasis - drug therapy ; Psoriasis - immunology ; Psoriasis - pathology</subject><ispartof>Journal of dermatology, 2015-04, Vol.42 (4), p.394-397</ispartof><rights>2015 Japanese Dermatological Association</rights><rights>2015 Japanese Dermatological Association.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.12798$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.12798$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25708520$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Imanishi, Akiko</creatorcontrib><creatorcontrib>Tateishi, Chiharu</creatorcontrib><creatorcontrib>Imanishi, Hisayoshi</creatorcontrib><creatorcontrib>Sowa-Osako, Junko</creatorcontrib><creatorcontrib>Koga, Hiroshi</creatorcontrib><creatorcontrib>Tsuruta, Daisuke</creatorcontrib><creatorcontrib>Hashimoto, Takashi</creatorcontrib><title>Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: Successful disease control with cyclosporin</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>Both anti‐laminin γ1 pemphigoid and bullous pemphigoid are autoimmune subepidermal blistering diseases. The former is rare and characterized by autoantibodies to laminin γ1, a 200‐kDa dermal protein, while the latter is common among the elderly and characterized by autoantibodies to BP180 and BP230, both of which are hemidesmosomal proteins. We experienced a 69‐year‐old Japanese male patient with blister formation secondary to erythrodermic psoriasis, which was successfully treated with cyclosporin. The histopathology of erythema corresponded with psoriasis and that of a blistering lesion showed infiltration of neutrophils and eosinophils in and around the subepidermal blisters. Patient immunoglobulin G antibodies labeled both the epidermal and dermal sides of 1 mol/L NaCl‐split human skin by indirect immunofluorescent microscopy and recognized laminin γ1, BP180 and BP230 by immunoblotting. To the best of our knowledge, this is the first report of coexistence of psoriasis and atypical pemphigoid with these three autoantibodies.</description><subject>Aged</subject><subject>Autoantibodies - metabolism</subject><subject>Autoantigens - immunology</subject><subject>BP180</subject><subject>Collagen Type XVII</subject><subject>cyclosporin</subject><subject>Cyclosporine - therapeutic use</subject><subject>Dystonin - immunology</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Laminin - immunology</subject><subject>laminin γ1</subject><subject>Male</subject><subject>Non-Fibrillar Collagens - immunology</subject><subject>pemphigoid</subject><subject>Pemphigoid, Bullous - drug therapy</subject><subject>Pemphigoid, Bullous - immunology</subject><subject>Pemphigoid, Bullous - pathology</subject><subject>psoriasis</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis - immunology</subject><subject>Psoriasis - pathology</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kc1O3DAQx62qqCy0596Qjz0Q8Fdsh1vZ8lGE2q1o1aPlOA4YnDjNJMA-Qx-n79Fnapbdri8ezfx-c5g_Qu8pOaLTO6ZcyExTro8oU4V-hWbbzms0I1znGRNE7aI9gHtCWJFT8gbtslwRnTMyQ78Xvunuwm0KFX4Kwx227RDKVAUPeEg42ia0ocV__9BDfLqgmkxANVWMk0NsAZILdvAbt4PUBwsB8OMYb20f4ATfjM55gHqMuArgLXjsUjv0Ka4dt3QxQTeJ7Vu0U9sI_t3m30c_zs--zy-z668Xn-cfr7PAuNCZZTn1RFqpK1pTZaXzRe0qwZngSuVKu8IVUnBXKisKWmvvRFlpXtelmG5W8H30Yb2369Ov0cNgmgDOx2hbn0YwVCrKqNRET-jBBh3Lxlem60Nj-6X5f8AJyNfAU4h-uZ1TYlb5mFUaZpWGecnHXH06eykmL1t7AQb_vPVs_2Ck4io3P79cmPPFNynV_Mrc8H_C1JIj</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Imanishi, Akiko</creator><creator>Tateishi, Chiharu</creator><creator>Imanishi, Hisayoshi</creator><creator>Sowa-Osako, Junko</creator><creator>Koga, Hiroshi</creator><creator>Tsuruta, Daisuke</creator><creator>Hashimoto, Takashi</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201504</creationdate><title>Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: Successful disease control with cyclosporin</title><author>Imanishi, Akiko ; Tateishi, Chiharu ; Imanishi, Hisayoshi ; Sowa-Osako, Junko ; Koga, Hiroshi ; Tsuruta, Daisuke ; Hashimoto, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i2348-a251e06a68d1f17a6ce9fcd4324377578c9c9643cb7a491f8ec4bd83ffb411193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Autoantibodies - metabolism</topic><topic>Autoantigens - immunology</topic><topic>BP180</topic><topic>Collagen Type XVII</topic><topic>cyclosporin</topic><topic>Cyclosporine - therapeutic use</topic><topic>Dystonin - immunology</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Laminin - immunology</topic><topic>laminin γ1</topic><topic>Male</topic><topic>Non-Fibrillar Collagens - immunology</topic><topic>pemphigoid</topic><topic>Pemphigoid, Bullous - drug therapy</topic><topic>Pemphigoid, Bullous - immunology</topic><topic>Pemphigoid, Bullous - pathology</topic><topic>psoriasis</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis - immunology</topic><topic>Psoriasis - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Imanishi, Akiko</creatorcontrib><creatorcontrib>Tateishi, Chiharu</creatorcontrib><creatorcontrib>Imanishi, Hisayoshi</creatorcontrib><creatorcontrib>Sowa-Osako, Junko</creatorcontrib><creatorcontrib>Koga, Hiroshi</creatorcontrib><creatorcontrib>Tsuruta, Daisuke</creatorcontrib><creatorcontrib>Hashimoto, Takashi</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Imanishi, Akiko</au><au>Tateishi, Chiharu</au><au>Imanishi, Hisayoshi</au><au>Sowa-Osako, Junko</au><au>Koga, Hiroshi</au><au>Tsuruta, Daisuke</au><au>Hashimoto, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: Successful disease control with cyclosporin</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2015-04</date><risdate>2015</risdate><volume>42</volume><issue>4</issue><spage>394</spage><epage>397</epage><pages>394-397</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><abstract>Both anti‐laminin γ1 pemphigoid and bullous pemphigoid are autoimmune subepidermal blistering diseases. The former is rare and characterized by autoantibodies to laminin γ1, a 200‐kDa dermal protein, while the latter is common among the elderly and characterized by autoantibodies to BP180 and BP230, both of which are hemidesmosomal proteins. We experienced a 69‐year‐old Japanese male patient with blister formation secondary to erythrodermic psoriasis, which was successfully treated with cyclosporin. The histopathology of erythema corresponded with psoriasis and that of a blistering lesion showed infiltration of neutrophils and eosinophils in and around the subepidermal blisters. Patient immunoglobulin G antibodies labeled both the epidermal and dermal sides of 1 mol/L NaCl‐split human skin by indirect immunofluorescent microscopy and recognized laminin γ1, BP180 and BP230 by immunoblotting. To the best of our knowledge, this is the first report of coexistence of psoriasis and atypical pemphigoid with these three autoantibodies.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>25708520</pmid><doi>10.1111/1346-8138.12798</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2015-04, Vol.42 (4), p.394-397
issn 0385-2407
1346-8138
language eng
recordid cdi_proquest_miscellaneous_1671216808
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Autoantibodies - metabolism
Autoantigens - immunology
BP180
Collagen Type XVII
cyclosporin
Cyclosporine - therapeutic use
Dystonin - immunology
Humans
Immunosuppressive Agents - therapeutic use
Laminin - immunology
laminin γ1
Male
Non-Fibrillar Collagens - immunology
pemphigoid
Pemphigoid, Bullous - drug therapy
Pemphigoid, Bullous - immunology
Pemphigoid, Bullous - pathology
psoriasis
Psoriasis - drug therapy
Psoriasis - immunology
Psoriasis - pathology
title Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: Successful disease control with cyclosporin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A56%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pemphigoid%20with%20antibodies%20to%20laminin%20%CE%B31,%20BP180%20and%20BP230,%20associated%20with%20psoriasis%20vulgaris:%20Successful%20disease%20control%20with%20cyclosporin&rft.jtitle=Journal%20of%20dermatology&rft.au=Imanishi,%20Akiko&rft.date=2015-04&rft.volume=42&rft.issue=4&rft.spage=394&rft.epage=397&rft.pages=394-397&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.12798&rft_dat=%3Cproquest_pubme%3E1671216808%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1671216808&rft_id=info:pmid/25708520&rfr_iscdi=true